Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13136843 | 1.00 | CYP2A6 (0.52) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL16627120 | 0.98 | CYP2A6 (0.50) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL14505881 | 0.98 | CYP2A6 (0.54) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL30670629 | 0.98 | CYP2A6 (0.54) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL29438468 | 0.95 | CYP2A6 (0.47) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL2246996 | 0.95 | CYP2A6 (0.47) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL29438465 | 0.95 | CYP2A6 (0.47) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL16344226 | 0.95 | CYP2A6 (0.47) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL14673069 | 0.95 | CYP2A6 (0.47) | CYP2A6TDP1CYP1A2CYP3A4MAPT | |
| SCHEMBL12722008 | 0.94 | TDP1 (0.44) | CYP2A6TDP1CYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1701592-B1 | A method of making an electroluminescent device | 3M INNOVATIVE PROPERTIES CO (US) | 2007-12-12 | — | — | EP | disclosed |
| EP-1722601-B1 | An electroluminescent device and a method of making the same | 3M INNOVATIVE PROPERTIES CO (US) | 2007-10-24 | — | — | EP | disclosed |
| EP-1703778-B1 | A method of making an electroluminescent device | 3M INNOVATIVE PROPERTIES CO (US) | 2007-09-12 | — | — | EP | disclosed |
| EP-1676467-B1 | ELECTROLUMINESCENT DEVICES AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1722601-A1 | An electroluminescent device and a method of making the same | 3M Innovative Properties Company (US) | 2006-11-15 | — | — | EP | disclosed |
| EP-1703778-A1 | A method of making an electroluminescent device | 3M Innovative Properties Company (US) | 2006-09-20 | — | — | EP | disclosed |
| EP-1701592-A1 | A method of making an electroluminescent device | 3M Innovative Properties Company (US) | 2006-09-13 | — | — | EP | disclosed |
| US-20040049080-A1 | Novel triphenylamines and use thereof | SHIROTA, YASUHIKO (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1300390-A1 | NOVEL TRIPHENYLAMINES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040049080-A1 | Novel triphenylamines and use thereof | NAT1, TPR, PNMT | CYP2A6 2949/4885TDP1 90/4885CYP1A2 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.